17:30 EDT C4 Therapeutics (CCCC) files $400M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCCC:
- C4 Therapeutics files to sell 4.87M shares of common stock for holders
- C4 Therapeutics reports Q3 EPS (35c), consensus (38c)
- C4 Therapeutics Appoints New Chief Scientific Officer
- C4 Therapeutics appoints Paige Mahaney, Ph.D., as Chief Scientific Officer
- C4 Therapeutics announces next steps for CFT1946